Search

everythinglearnresearchcommunity

for

Search:↓

The gel with apigenin and celery juice promotes hair growth without causing skin irritation.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Tofacitinib may effectively treat folliculitis decalvans.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tattoos may trigger autoimmune symptoms in some people.

Injecting monocyto-angiotropin into hare skin increases hair growth by forming new blood vessels.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

The PI's development is closely linked to skin and hair pigmentation in macaques.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Acupuncture therapy significantly reduced hair loss in women aged 31-50 with female pattern hair loss.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.